Mark Verheijen
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (10)
Year:
2025
Alzheimer's disease (AD) is a progressive neurodegenerative disease and the most common cause of dementia, characterized by deposition of extracellular amyloid‐beta (Aβ) aggregates and intraneuronal hyperphosphorylated Tau. Many AD risk genes, identified in genome‐wide association studies (GWAS), are expressed in microglia, the innate immune cells of the central nervous system. Specific subtypes of microglia emerged in relation to AD pathology, such as disease‐associated microglia (DAMs), which increased in number with age in amyloid mouse models and in human AD cases. However, the initial transcriptional changes in these microglia in response to amyloid are still unknown. Here, to determine early changes in microglia gene expression, hippocampal microglia from male APPswe/PS1dE9 (APP/PS1) mice and wild‐type littermates were isolated and analyzed by RNA sequencing (RNA‐seq). By bulk RNA‐seq, transcriptomic changes were detected in hippocampal microglia from 6‐months‐old APP/PS1 mice. By performing single‐cell RNA‐seq of CD11c‐positive and negative microglia from 6‐months‐old APP/PS1 mice and analysis of the transcriptional trajectory from homeostatic to CD11c‐positive microglia, we identified a set of genes that potentially reflect the initial response of microglia to Aβ.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2020
Year:
2020
Collaborators (8)
Darshan Sapkota
University of Texas at Dallas
Huib Mansvelder
University of Amsterdam
Michel van den Oever
University of Amsterdam
Sabine Spijker
Full professor
-
Bart J. L. Eggen
-
Jan van Weering
University of Amsterdam
Rogier Min
University of Amsterdam
Thomas Blok
Vrije Universiteit Amsterdam
Make your next move.
Prepare your application
Review drafts before you send them.